health.tech 2024

Strategies from a University Hospital and TUM Venture Labs start-ups

Join this session to gain a comprehensive view of the current state of AI deployment, including existing use cases and prevalent challenges. You will hear about the status quo, as well as future perspectives from the Chief Medical Information Officer (CMIO) at university hospital “Klinikum Rechts der Isar” one of Germanys leading university hospitals. Additionally, benefit from perspectives shared by TUM Venture Lab Healthcare and startup founders of Brightmind.AI and Ryver.AI, offering a holistic view of the use of AI in the spectrum spanning from medtech to digital health to biopharma. Take this opportunity to discover strategies and collaborations driving the AI revolution in healthcare.

Hosted by Dominik Pförringer (Academic Director TUM Venture Labs, Healthcare)

Panelists: 

• Tamara Gerbert, Co-founder, Brightmind.AI
• Christoph Spinner, Chief Medical Information Officer, TUM, University Hospital Klinikum
• Jonas Ils, Co-Founder & CEO, RYVER.AI
• PD Dr. med. Kilian Schiller, Venture Director, TUM Venture Labs, Healthcare

Stage: DEEP DIVE A

Bavaria is the No. 1 E-Health Region, within Germany. And to keep it that way, Bavaria's high-performance healthcare industry must learn to master new challenges connected to the European Health Data Space (EHDS). The EHDS framework, which is currently in the EU legislative process, offers immense opportunities for data-driven innovations.

In this deep dive session, we will recapitulate the goals and challenges of the EHDS and to discuss its concrete impact on Bavaria as an e-health region. We will answer questions including: How will legislation affect access, use and exchange of health data? And do we need a separate, compatible health data space for Bavaria? What connected opportunities are there for start-ups, research, as well as medical and nursing care?
 

Our experts will offer insights into the legal, technical, ethical and practical aspects of the EHDS and discuss how Bavaria can strengthen its position as a pioneer in the digital health revolution.

Hosted by Dominik Pförringer (Academic Director, TUM Venture Labs, Healthcare)

Keynote speaker: 

• Birgit Bauer, Founder and Project Coordinator, Data Saves Lives Germany
• Franz Leisch,CDO, PRAEVENIRE
• Bjoern Eskofier, Head of Machine Learning and Data Analytics Lab, FAU

Stage: Euro Vision Health

Deep tech innovation holds tremendous potential for transforming industries and addressing complex societal challenges. However, the journey from laboratory research to market-ready products or services is often long and challenging. In this panel discussion, experts in deep tech venturing will explore the pathways for transferring research results into industrial applications. The discussion will cover various aspects, including the role of talent mobilization, startups, industry-academia collaboration, government support, and the macro-economic development implications of deep tech innovation. By delving into these topics, the panel aims to provide insights into the challenges, opportunities, and best practices for navigating the complex journey of deep tech innovation from lab to market

Hosted by Sabine Klein (Managing Director, TUM Venture Labs, Healthcare)

Keynote speaker: 

• Dan Ma, Head of Innovation & New Commercial Partnerships, Sandoz
• Stephan Sieber,Head of Chair, TUM, Chair of Organic Chemistry
• Robin Allert,CEO, QTAS
• Fei Tian,Principal, MIG Capital

Stage: DEEP DIVE A

micro factory is pioneering in Resin-based 3D printing by launching a desktop machine that automates printing, washing, curing an part ejection.

Represented by Maximilian Straßer (CEO)

Personalized brain stimulation brought to everyday life. A novel, effective approach to migraine prevention at home.

Represented by Tamara Gerbert (Co-Founder)

GST offers the world's leading technology platform for sustainable biomaterials and active ingredients production.

Represented by Mahmoud Masri (Co-Founder & CEO)

QTAS revolutionizes tumor treatment using novel quantum sensors resulting in 25 times reduction in time between drug administration and treatment assessment, significantly reducing costs and saving lives.

Represented by Robin Allert (CEO)

smartbax develops a new generation of antibiotics against multi-drug resistant bacteria, focussing on novel modes of action and enzyme activation instead of inhibition.

Represented by Dr. Robert Macsics (Co-Founder & CEO)

panthr is an oncology-focused startup offering AI-supervised, personalized, and autonomous exercise therapy using smart textile wearable technology to improve outcomes.

Represented by Alexander Krause (Co-Founder & CEO)

MySympto is developing an AI-supported virtual assistant that supports doctors in emergency rooms in decision-making and improves efficiency.

Represented by Nils Bergmann (Co-Founder)

ExoSphere develops diagnostic kits for screening of individuals at high risk of aggressive cancer types.

Represented by Negar Shahmoradi (Co-Founder)

ImuVeo is developing imaging solutions for Cancer Immunotherapy.

Represented by Paul Klein (Head of Operations)